FORM 5
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
[ ] Form 3 Holdings Reported
[ ] Form 4 Transactions Reported		 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

                                                                                  
 OMB APPROVAL
OMB Number: 3235-0362
Estimated average burden
hours per response... 1.0
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

WITHROW EDWARD W III		2. Issuer Name and Ticker or Trading Symbol

PARALLAX HEALTH SCIENCES, INC. [PRLX]		 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    __X__ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

3415 S SEPULVEDA BLVD,  SUITE 1100-1234		3. Statement for Issuer's Fiscal Year Ended (MM/DD/YYYY)
12/31/2021 
(Street)

LOS ANGELES, CA 90034
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed(MM/DD/YYYY)
 
6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form Filed by One Reporting Person
___ Form Filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		2. Trans. Date2A. Deemed Execution Date, if any3. Trans. Code
(Instr. 8)		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Amount(A) or (D)Price
PREFERRED STOCK (SERIES A) 9/30/2011 (1) J5 (1)36339 A$2.75 399732 I By Huntington Chase Financial Group 
PREFERRED STOCK (SERIES A) 11/6/2021  J (2)396339 A$0 796071 I By Huntington Chase Financial Group 
PREFERRED STOCK (SERIES A) 11/6/2021  J (3)796071 D$0 0 I By Huntington Chase Financial Group 
COMMON STOCK 11/6/2021  J (3)15921420 (3)A$0 72430792 I By Huntington Chase LLC 

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)		2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date
(MM/DD/YYYY)		7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)		8. Price of Derivative Security
(Instr. 5)		9. Number of Derivative Securities Beneficially Owned at End of Issuer's Fiscal Year
(Instr. 4)		10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		11. Nature of Indirect Beneficial Ownership
(Instr. 4)
(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
STOCK OPTION $0.25 3/31/2021  D   3000000 (4)  (4)12/31/2022 COMMON STOCK 3000000 $0 1000000 I By Huntington Chase LLC 
Explanation of Responses:
(1) Additional Series A Preferred shares acquired; not included in previous Form 5 for the year 12/31/2012. Total Series A Preferred shares held at 12/31/12 = 399,732.
(2) Cumulative dividends in kind on Series A Preferred Stock.
(3) Conversion of preferred stock into common stock at a ratio of 20 shares of common stock for each share of preferred stock.
(4) Unvested stock options canceled upon resignation of Reporting Person.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
WITHROW EDWARD W III
3415 S SEPULVEDA BLVD
SUITE 1100-1234
LOS ANGELES, CA 90034
X
Signatures
EDWARD W. WITHROW III3/17/2022
**Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Parallax Health Sciences (CE) (USOTC:PRLX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Parallax Health Sciences (CE) Charts.
Parallax Health Sciences (CE) (USOTC:PRLX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Parallax Health Sciences (CE) Charts.